Literature DB >> 21569090

KIT amplification and gene mutations in acral/mucosal melanoma in Korea.

Jina Yun1, Jeeyun Lee, Jiryeon Jang, Eui Jin Lee, Kee Taek Jang, Jung Han Kim, Kyoung-Mee Kim.   

Abstract

Mucosal and acral melanomas have demonstrated different genetic alterations and biological behavior compared with more common cutaneous melanomas. It was recently reported that gain-of-function KIT mutations and/or copy number increases are more common in mucosal and acral melanomas. Thus, we studied the frequency and pattern of KIT aberrations in mucosal and acral melanomas in Korea. We analyzed 97 patients who were pathologically confirmed with mucosal or acral melanoma between 1997 and 2010 at Samsung Medical Center. Of the 97 melanoma patients, 92 were screened for mutations in KIT exons 11, 13, 17, and 18, BRAF and NRAS genes. KIT copy number was assessed by quantitative, real-time PCR. Of the 97 patients, 55 (56.7%) were mucosal, 40 (41.2%) were acral melanoma, and two were of unknown primary origin. Among seven cases with KIT mutation, five (60.0%) occurred in exon 11, one (20.0%) in exon 17, and one (20.0%) in exon 13. Point mutations were the most common, resulting in substitutions in exon 11 (K558R, T574A, L576P, and V559A), exon 13 (N655K), and exon 17 (N822K). A novel Thr574Ala (c.1720A>G) KIT mutation, which has not been reported in melanoma or other tumor types, was identified in one genital melanoma case. Of the 97 mucosal or acral melanoma specimens, 49 were tested for KIT gene copy number changes using quantitative PCR. Increased KIT copy number was identified in 15 patients: seven (40%) of 20 acral melanomas and eight (31%) of 26 mucosal melanomas. Our study implicates that a significant proportion of acral and mucosal melanomas have KIT mutations in Asian population.
© 2011 The Authors. APMIS © 2011 APMIS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569090     DOI: 10.1111/j.1600-0463.2011.02737.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  22 in total

Review 1.  Molecular targets in melanoma: time for 'ethnic personalization'.

Authors:  Shane Y Morita; Svetomir N Markovic
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 2.  Improving the diagnosis and treatment of acral melanocytic lesions.

Authors:  Maressa C Criscito; Jennifer A Stein
Journal:  Melanoma Manag       Date:  2017-05-19

Review 3.  Is UV an etiological factor of acral melanoma?

Authors:  Lin Liu; Weigang Zhang; Tianwen Gao; Chunying Li
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-10-14       Impact factor: 5.563

Review 4.  Sinonasal tumors: a clinicopathologic update of selected tumors.

Authors:  Pieter J Slootweg; Alfio Ferlito; Antonio Cardesa; Lester D R Thompson; Jennifer L Hunt; Primož Strojan; Robert P Takes; Asterios Triantafyllou; Julia A Woolgar; Alessandra Rinaldo; Kenneth O Devaney; Leon Barnes
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-18       Impact factor: 2.503

Review 5.  The mutational landscape of mucosal melanoma.

Authors:  Kelsey W Nassar; Aik Choon Tan
Journal:  Semin Cancer Biol       Date:  2019-10-23       Impact factor: 15.707

6.  Nilotinib in patients with metastatic melanoma harboring KIT gene aberration.

Authors:  Jin Hyun Cho; Kyoung Mee Kim; Miyeon Kwon; Jung Han Kim; Jeeyun Lee
Journal:  Invest New Drugs       Date:  2011-11-09       Impact factor: 3.850

7.  Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).

Authors:  Su Jin Lee; Tae Min Kim; Yu Jung Kim; Kee-Taek Jang; Hyo Jin Lee; Soon Nam Lee; Mi Sun Ahn; In Gyu Hwang; Suee Lee; Moon-Hee Lee; Jeeyun Lee
Journal:  Oncologist       Date:  2015-09-30

8.  Targeted agents for the treatment of metastatic melanoma.

Authors:  Jose G Monzon; Janet Dancey
Journal:  Onco Targets Ther       Date:  2012-03-05       Impact factor: 4.147

Review 9.  Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.

Authors:  Patricia Basurto-Lozada; Christian Molina-Aguilar; Carolina Castaneda-Garcia; Martha Estefania Vázquez-Cruz; Omar Isaac Garcia-Salinas; Alethia Álvarez-Cano; Héctor Martínez-Said; Rodrigo Roldán-Marín; David J Adams; Patricia A Possik; Carla Daniela Robles-Espinoza
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

Review 10.  More than just acral melanoma: the controversies of defining the disease.

Authors:  Sara S Bernardes; Ingrid Ferreira; David E Elder; Aretha B Nobre; Héctor Martínez-Said; David J Adams; Carla Daniela Robles-Espinoza; Patricia A Possik
Journal:  J Pathol Clin Res       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.